Elise E DeVito1, Gerald W Valentine2, Aryeh I Herman1, Kevin P Jensen1, Mehmet Sofuoglu3. 1. Associate Research Scientist in Psychiatry, Yale School of Medicine, New Haven, CT. 2. Clinician in Psychiatry, Yale School of Medicine, New Haven, CT. 3. Professor of Psychiatry, Yale School of Medicine, New Haven, CT.
Abstract
OBJECTIVES:Menthol, a flavoring agent, is found in approximately 90% of cigarettes, but at much higher levels in menthol than non-menthol cigarettes. Menthol is reportedly included in cigarettes for its cooling and soothing effects, but also additional actions that affect smokers' receipt and processing of nicotine. In this study we investigated the response to short-term abstinence and acute nicotine delivery in menthol-preferring and non-menthol-preferring smokers. METHODS:Nicotinedependent participants (N = 134) participated in anintravenous nicotine delivery session following overnight smoking abstinence. Participants were intravenously administered a placebo and 2 escalating nicotine doses. We compare subjective and physiological responses to nicotine and smoking urges, withdrawal, and cognitive performance following overnight abstinence and post-nicotine between regular 'menthol' smokers and 'non-menthol' cigarette smokers. RESULTS: Relative to non-menthol-preferring smokers, menthol-preferring smokers re a smaller reduction in smoking urges from overnight abstinence baseline to post-nicotine end-of-session and rated less subjective differences between nicotine doses. CONCLUSIONS: Differences between menthol-preferring and non-menthol-preferring smokers' responses to abstinence or acute nicotine could reflect pre-existing individual differences that may have in initial development of menthol preferences, or could have arisen secondarily to pro use of menthol versus non-menthol cigarettes.
RCT Entities:
OBJECTIVES:Menthol, a flavoring agent, is found in approximately 90% of cigarettes, but at much higher levels in menthol than non-menthol cigarettes. Menthol is reportedly included in cigarettes for its cooling and soothing effects, but also additional actions that affect smokers' receipt and processing of nicotine. In this study we investigated the response to short-term abstinence and acute nicotine delivery in menthol-preferring and non-menthol-preferring smokers. METHODS:Nicotine dependent participants (N = 134) participated in an intravenous nicotine delivery session following overnight smoking abstinence. Participants were intravenously administered a placebo and 2 escalating nicotine doses. We compare subjective and physiological responses to nicotine and smoking urges, withdrawal, and cognitive performance following overnight abstinence and post-nicotine between regular 'menthol' smokers and 'non-menthol' cigarette smokers. RESULTS: Relative to non-menthol-preferring smokers, menthol-preferring smokers re a smaller reduction in smoking urges from overnight abstinence baseline to post-nicotine end-of-session and rated less subjective differences between nicotine doses. CONCLUSIONS: Differences between menthol-preferring and non-menthol-preferring smokers' responses to abstinence or acute nicotine could reflect pre-existing individual differences that may have in initial development of menthol preferences, or could have arisen secondarily to pro use of menthol versus non-menthol cigarettes.
Entities:
Keywords:
craving; intravenous nicotine; menthol; smoking urges; subjective drug effects
Authors: Elise E DeVito; Aryeh I Herman; Andrew J Waters; Gerald W Valentine; Mehmet Sofuoglu Journal: Neuropsychopharmacology Date: 2013-12-18 Impact factor: 7.853
Authors: Y Wendy Huynh; Anthony Raimondi; Andrew Finkner; Jordan D Kuck; Carly Selleck; Rick A Bevins Journal: Psychopharmacology (Berl) Date: 2020-05-24 Impact factor: 4.530
Authors: Gerald W Valentine; Elise E DeVito; Peter I Jatlow; Ralitza Gueorguieva; Mehmet Sofuoglu Journal: J Psychopharmacol Date: 2018-05-23 Impact factor: 4.153
Authors: Ralitza Gueorguieva; Elizabeth K C Schwartz; R Ross MacLean; Elise E DeVito; Tore Eid; Ran Wu; Stephanie S O'Malley; Mehmet Sofuoglu Journal: Front Pharmacol Date: 2022-03-31 Impact factor: 5.810
Authors: R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; MacKenzie R Peltier; Suprit Parida; Mehmet Sofuoglu Journal: Exp Clin Psychopharmacol Date: 2020-05-28 Impact factor: 3.157